Heath Law Alliance is proud to announce a major legal victory on behalf of its pharmacy client in California: the full reversal of a Medi-Cal (California Medicaid) payment suspension imposed by the California Department of Health Care Services (DHCS).
Medi-Cal payment suspensions are serious administrative actions that can jeopardize a pharmacy’s business operations, reputation, and its ability to service its patients. These payment suspensions are often triggered by preliminary audit findings and/or other unverified suspicions of wrongdoing. In this case, DHCS initiated a payment suspension based on speculative allegations and incomplete evidence.
Heath Law Alliance intervened immediately. Our legal team crafted a number of strategic and persuasive appeals, demonstrating that the Department’s allegations failed to meet the legal standards required under both state and federal law. After a thorough review, the Office of Administrative Hearings and Appeals agreed with our position and issued a decision reversing the payment suspension in full.
This outcome underscores the importance of experienced legal counsel when dealing with Medicaid and/or any other insurance payors. It highlights our firm’s commitment to aggressive advocacy and unwavering defense of healthcare providers’ rights and business operations.
How Health Law Alliance Can Help
If your pharmacy is facing insurance payment suspensions, network terminations, investigations, and/or PBM audits, Heath Law Alliance stands ready to defend your practice and challenge unjust enforcement actions. With extensive experience in healthcare law, Medicaid and Medicare regulations, pharmacy provider defense, and litigation, our law firm is uniquely positioned to safeguard your interests and help secure the future of your pharmacy business.
Contact us today to schedule a free consultation.
MORE ARTICLES BY CATEGORY
Texas Moves to Rein in Ketamine Therapy—And Other States are Likely Next
The regulatory environment surrounding ketamine therapy is entering a new phase of maturity and enforcement. Recently, the Texas Medical Board published proposed regulations governing ketamine therapy, one of the first comprehensive regulatory frameworks in the country.
Read More >>California Hospice Fraud Crackdown: What it Means for Providers & How to Protect Your Business
California’s hospice fraud crackdown is only the beginning of what CMS and Medi-Cal regulators have claimed will be many more cases brought against hospice facilities and home health agencies. Providers who do not timely respond to a suspension or revocation may waive important rights. Act now to protect your business and reputation from governmental overreach based on data mining and other unreliable sources.
Read More >>New Executive Order Signals Faster Psychedelic Drug Approvals--and Closer DEA Scrutiny
On Saturday, April 18, President Trump signed an executive order designed to accelerate federal drug approvals for psychedelic drugs, a move experts are calling a significant win for patient access. But for ketamine providers and practices offering ketamine-assisted psychotherapy (KAP), increased coordination among regulators means increased scrutiny is inevitable. In this article, we break down what this executive order means for the future of regulatory enforcement.
Read More >>The WISeR Model: A New Era of Prior Authorization and Audit Risks for Wound Care
On January 1, 2026, the Centers for Medicare & Medicaid Services (CMS) officially launched the Wasteful and Inappropriate Service Reduction (WISeR) Model. This initiative is not just another administrative hurdle; it is a technology-driven enforcement overhaul aimed directly at the wound care industry.
Read More >>
